Literature DB >> 27883270

Pharmacovigilance Skills, Knowledge and Attitudes in our Future Doctors - A Nationwide Study in the Netherlands.

Tim Schutte1,2,3, Jelle Tichelaar1,2,3, Michael O Reumerman2, Rike van Eekeren4,5,6, Robert Rissmann1,7,8, Cornelis Kramers1,9, Milan C Richir1,2,3, Eugène P van Puijenbroek4,5,6, Michiel A van Agtmael2,3.   

Abstract

Pharmacovigilance centres monitor the safety of drugs, based on adverse drug reactions (ADRs) reported by doctors, pharmacists and pharmaceutical companies. However, the under-reporting of ADRs remains a major problem. Our aim was to investigate preparedness of future doctors for their role in pharmacovigilance, by assessing their pharmacovigilance awareness, skills and knowledge. The study was a nationwide e-survey among medical students (third to sixth year) of all eight medical schools in the Netherlands. The survey consisted of questions regarding pharmacovigilance awareness, skills and knowledge. Overall, 874 students provided informed consent and participated (response 12%). Almost all students (96%) intended to report serious ADRs in their future practice. Almost half (44%) of the students did not know where to report an ADR, and 78% did not know which items were necessary for a good-quality ADR report. While more than 78% of the students agreed that pharmacovigilance is an important topic in their medical education, only 26% found that their current curriculum covered pharmacovigilance adequately. Although ADR reporting is considered relevant and important among future doctors, many do not know where and what to report. This is highly undesirable and should have consequences for pharmacotherapy teaching.
© 2016 The Authors. Basic & Clinical Pharmacology & Toxicology published by John Wiley & Sons Ltd on behalf of Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Mesh:

Year:  2017        PMID: 27883270     DOI: 10.1111/bcpt.12712

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  9 in total

1.  Drugs for rare disorders.

Authors:  Serge Cremers; Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2017-06-27       Impact factor: 4.335

2.  Feasibility and Educational Value of a Student-Run Pharmacovigilance Programme: A Prospective Cohort Study.

Authors:  Tim Schutte; Jelle Tichelaar; Michael O Reumerman; Rike van Eekeren; Leàn Rolfes; Eugène P van Puijenbroek; Milan C Richir; Michiel A van Agtmael
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

3.  Do final-year medical students have sufficient prescribing competencies? A systematic literature review.

Authors:  David J Brinkman; Jelle Tichelaar; Sanne Graaf; René H J Otten; Milan C Richir; Michiel A van Agtmael
Journal:  Br J Clin Pharmacol       Date:  2018-01-25       Impact factor: 4.335

4.  Healthcare students' knowledge, attitude and perception of pharmacovigilance: A systematic review.

Authors:  Monira Alwhaibi; Noha A Al Aloola
Journal:  PLoS One       Date:  2020-05-20       Impact factor: 3.240

5.  What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects.

Authors:  Rike van Eekeren; Leàn Rolfes; Andries S Koster; Lara Magro; Gurumurthy Parthasarathi; Hussain Al Ramimmy; Tim Schutte; Daisuke Tanaka; Eugène van Puijenbroek; Linda Härmark
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.606

Review 6.  Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature.

Authors:  Michael Reumerman; J Tichelaar; B Piersma; M C Richir; M A van Agtmael
Journal:  Eur J Clin Pharmacol       Date:  2018-06-20       Impact factor: 2.953

7.  Pharmacovigilance and Its Importance for Primary Health Care Professionals.

Authors:  Asma A'tiyah Abdul Hamid; Rashidah Rahim; Shyh Poh Teo
Journal:  Korean J Fam Med       Date:  2022-09-20

8.  The adverse drug reaction reporting assignment for specialist oncology nurses: a preliminary evaluation of quality, relevance and educational value in a prospective cohort study.

Authors:  Tim Schutte; Rike van Eekeren; Milan Richir; Jojanneke van Staveren; Eugène van Puijenbroek; Jelle Tichelaar; Michiel van Agtmael
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-10-23       Impact factor: 3.000

9.  Knowledge of Adverse Drug Reaction Reporting and the Pharmacovigilance of Biological Medicines: A Survey of Healthcare Professionals in Ireland.

Authors:  J O'Callaghan; B T Griffin; J M Morris; Margaret Bermingham
Journal:  BioDrugs       Date:  2018-06       Impact factor: 5.807

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.